Arestin-Enhanced SRP for Periodontitis and Diabetes
This study is looking at how adding Arestin (minocycline microspheres), a local antibiotic, to a common dental cleaning procedure called Scaling and Root Planing (SRP) affects people with type 2 diabetes and gum disease (periodontitis). Researchers want to see if this combination treatment helps close gum pockets, improves blood sugar control, and reduces overall body inflammation. You might be able to join if you are an adult (18 or older) with type 2 diabetes (HbA1c between 7.0% and 9.5%) and moderate to severe periodontitis. You also need at least 16 teeth and no recent gum treatment. The study aims to enroll 42 participants, but its current status is unclear.
- Study design
- This study is interventional and plans to enroll 42 participants. It compares two treatments: Scaling and Root Planing (SRP) alone versus SRP with the addition of Arestin.
- What's involved
- You would receive either Scaling and Root Planing (SRP) alone or SRP with Arestin. Your gum pocket closure will be measured at the start, after 3 months, and after 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after treatment, with measurements taken at 3 and 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Gian Pietro Schincaglia, DDS, PhD · PRINCIPAL_INVESTIGATOR · Case Western Reserve University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Pocket ClosureBaseline, 3 Months, 6 Months
Pocket Depth (PD ≤4 mm)